首页> 外国专利> tumor vaccination by utilizing autologous cells or antigen presenting cells (APC) related hla transduced with a tumor antigen and a foreign antigen capable of causing an immune reaction.

tumor vaccination by utilizing autologous cells or antigen presenting cells (APC) related hla transduced with a tumor antigen and a foreign antigen capable of causing an immune reaction.

机译:通过利用自体细胞或抗原呈递细胞(APC)相关的hla转导肿瘤疫苗,所述hla经肿瘤抗原和能够引起免疫反应的外源抗原转导。

摘要

DESCRIBES A PROCEDURE FOR VACCINATION TUMOR WITH AT LEAST two subsequent administrations of a composition comprising autologous OR RELATED HLA ARE ABLE TO SUBMIT A antigen in a patient, cells are either transduced tumor cells with a gene not inherited PATIENT (GEN STRANGE) or antigen presenting cells (APCs) transduced with a tumor antigen and an antigen STRANGE. This method is the destruction of TUMOR THROUGH THE IMMUNE RESPONSE.
机译:描述一种用于至少在随后两次给予包含自体或相关HLA的组合物的疫苗接种疫苗的方法,所述组合物可以在患者体内呈递抗原,所述细胞是具有非遗传患者基因(GEN STRANGE)的转导肿瘤细胞或呈递抗原的细胞(APC)用肿瘤抗原和抗原STRANGE转导。这种方法是通过免疫反应破坏肿瘤。

著录项

  • 公开/公告号ES2232845T3

    专利类型

  • 公开/公告日2005-06-01

    原文格式PDF

  • 申请/专利权人 SCIENCE PARK RAF S.P.A.;

    申请/专利号ES19970114514T

  • 发明设计人 BORDIGNON CLAUDIO;TRAVERSARI CATIA;

    申请日1997-08-22

  • 分类号A61K39/00;A61K48/00;

  • 国家 ES

  • 入库时间 2022-08-21 22:14:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号